Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study

Carlo Cattrini, Luigi Cerbone, Alessandra Rubagotti, Linda Zinoli, Maria Maddalena Latocca, Carlo Messina, Elisa Zanardi, Francesco Boccardo

Research output: Contribution to journalArticlepeer-review

Abstract

This study retrospectively analyzed the United States Surveillance, Epidemiology, and End Results (SEER) Database. We found that the use of chemotherapy is associated with better outcome in patients with non-metastatic small-cell neuroendocrine carcinoma of the bladder. We also found that patients with T2 disease treated with surgery show better survival compared with those treated with radiotherapy.

Original languageEnglish
Pages (from-to)e724-e732
JournalClinical Genitourinary Cancer
Volume17
Issue number4
DOIs
Publication statusPublished - Aug 1 2019

Keywords

  • Neuroendocrine bladder cancer
  • Prognostic variables
  • SCCB
  • SEER
  • Small-cell bladder cancer

ASJC Scopus subject areas

  • Oncology
  • Urology

Fingerprint Dive into the research topics of 'Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study'. Together they form a unique fingerprint.

Cite this